Larimar Therapeutics, Inc. - COM (LRMR)

Historical Portfolio Holders from Q2 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
65.3M
Holdings value Q2 2024
$473M
Value change Q2 2024
+$12.2M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
105
Number of buys Q2 2024
61
Number of sells Q2 2024
-54
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 65.3M $473M +$12.2M $7.25 105
2024 Q1 63.6M $483M +$184M $7.59 104
2023 Q4 39.5M $180M +$15.2M $4.55 68
2023 Q3 38.7M $153M -$760K $3.95 63
2023 Q2 39M $120M -$3.77M $3.13 65
2023 Q1 38.5M $174M +$995K $4.53 68
2022 Q4 38.8M $160M +$976K $4.13 47
2022 Q3 38.7M $124M +$77.8M $3.20 50
2022 Q2 14.4M $28.2M -$2.24M $1.96 34
2022 Q1 15.3M $61.8M -$2.59M $4.05 41
2021 Q4 14.6M $157M +$872K $10.79 47
2021 Q3 14.4M $166M -$889K $11.53 48
2021 Q2 14.5M $143M -$4.48M $9.82 42
2021 Q1 14.1M $206M -$8.48M $14.61 54
2020 Q4 13.8M $295M +$5.24M $21.41 40
2020 Q3 13.6M $207M +$10.1M $15.17 37
2020 Q2 12.9M $166M +$166M $12.85 34